Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix, Lacking Roche Revenue, Posts Steep Decline in Q1 Receipts As Profit Turns to Loss

NEW YORK, April 28 (GenomeWeb News) - Acacia's CombiMatrix group yesterday reported a steep decline in revenues and a net loss for the first quarter of 2005.


Revenues for the quarter were $1.1 million, down from $17.6 million during the same quarter in 2004. Last year's figures included $17.3 million in deferred revenues from CombiMatrix's alliance with Roche.


R&D costs decreased slightly, to $1.1 million, from $1.4 million during last year's first quarter.


CombiMatrix's net loss for the quarter was $3.1 million, compared to a profit of $11.9 million during the same quarter in 2005, which was primarily driven by the recognition of the Roche contract revenues in that quarter.


As of March 31, CombiMatrix had $20.4 million in cash, cash equivalents, and short-term investments.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.